New Catalysts for Brain-Computer Interface Emerging Continuously, Pay Attention to [Fangzheng Medical Team] for Continuous Deep Tracking!!

English summary

Recently, brain-computer interface related stocks in the market continue to see volume increase. We believe it is mainly due to major breakthroughs in technology, registration, and commercialization in the domestic and foreign industry chain: Overseas, Neuralink has completed over 20 implantations, visual Blindsight will start clinical trials within the year, the leading advantage and asset scarcity of invasive technology drive its valuation surge; in addition, the prima retinal implant system developed by Science Corp received CE approval, expected to begin first commercial implantation in August, marking an important milestone in the commercialization of overseas brain-computer interface and neural implant devices. Domestically, non-invasive focus on the rehabilitation field accelerating hospital entry and commercial transformation, and invasive brain-computer interface has also completed the first commercial implantation: Neuracle NEO was included in 'Shanghai Huimin Insurance' in May, and completed the first commercial implantation in July, the monetization path of invasive brain-computer interface gradually emerging. ...